Embolization versus myomectomy versus hysterectomy: Which is best, when?

Human Reproduction

Volumn 17, Issue 2, 2002, Pages 253-259

  Lumsden, Mary Ann ^a,b  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b QUEEN MOTHER S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DANAZOL; GONADORELIN AGONIST; PROSTAGLANDIN SYNTHASE INHIBITOR;

ABDOMINAL HYSTERECTOMY; CLINICAL TRIAL; COLLATERAL CIRCULATION; COMPARATIVE STUDY; CONCEPTION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG EFFICACY; FEMALE; FEMALE FERTILITY; FEMALE GENITAL TRACT TUMOR; HUMAN; HYSTERECTOMY; HYSTEROSCOPY; LAPAROSCOPIC SURGERY; MENSTRUATION DISORDER; MORBIDITY; MYOMECTOMY; PATIENT SATISFACTION; PERITONEUM ADHESION; POSTOPERATIVE COMPLICATION; RANDOMIZED CONTROLLED TRIAL; REVIEW; SHORT COURSE THERAPY; SUBFERTILITY; SYMPTOM; UTERINE ARTERY EMBOLIZATION; UTERUS BLOOD FLOW; UTERUS MYOMA; VAGINAL HYSTERECTOMY;

EID: 0036180661     PISSN: 02681161     EISSN: None     Source Type: Journal    
DOI: 10.1093/humrep/17.2.253     Document Type: Review

References (64)

1. Transcervical expulsion of a fibroid as a result of uterine artery embolization of leimyomata
2. Fibroid embolization: A technique not without significant complications
3. Fibroids, infertility and pregnancy wastage
4. Vaginal expulsion of submucosal fibroids after uterine artery embolization: A report of three cases
5. Hysterectomy: A review of the literature on indications, effectiveness and risks
6. Transcatheter uterine artery embolisation to treat large uterine fibroids
7. Embolization of uterine leiomyomata: Current concepts in management
8. A Scottish audit of laparoscopically assisted vaginal hysterectomy
9. Uterine artery embolisation: A systematic review of the literature and proposal for research
10. An agenda for research into uterine artery embolization: Results of an expert panel conference
11. Uterine leiomyomata: Etiology, symptomatology and management
12. Medical management of uterine fibromyomata
13. The long term effectiveness of hysteroscopic treatment of menorrhagia and leiomyomas
14. Randomised controlled trial comparing endometrial resection with abdominal hysterectomy for the surfical treatment of menorrhagia
15. Recurrent of leiomyomata after myomectomy
16. Recurrence of fibroids after myomectomy: A transvaginal ultrasonographic study
17. Uterine rupture during pregnancy
18. Outcome of hysteroscopic resection of submucous myomas for infertility
19. Preliminary experience with uterine artery embolization for uterine fibroids
20. Uterine artery embolisation for the treatment of uterine leiomyomata. Mid term results
21. A nationwide analysis of laparoscopic complications
22. Finnish national register of laparoscopic hysterectomies: A review and complications of 1165 operations
23. Selective uterine artery embolization as primary treatment for symptomatic leiomyomata uteri: A review of 305 consecutive cases
24. Relative morbidity of abdominal hysterectomy and myomectomy for management of uterine leiomyomas
25. Hysterectomy and race
26. Uterine leiomyomas: Racial differences in severity, symptoms and age at diagnosis
27. Management in intractable obstetric haemorrhage: An audit study on 61 cases
28. Hysterectomy surveillance - United States, 1980-1993
29. Uterine artery embolization for the treatment of symptomatic uterine fibroids: A review
30. Myomectomy at the Chelsea Hospital for Women
31. Clinical presentation of uterine fibroids
32. The binding of epidermal growth factor to the human uterus on leiomyomata in women rendered hypo-oestrogenic by continuous administration of LHRH agonist
33. The binding of steroids to myometrium and leiomyomata (fibroids) in women treated with the gonadotrophin-releasing hormone agonist Zoladex (ICI 118630)
34. A randomised comparison and economic evaluation of laparoscopic assisted hysterectomy and abdominal hysterectomy
35. Reduction of pelvic radiation during uterine fibroid embolization (UFE): Bilateral versus unilateral femoral artery access
36. Treatment of peri-menopausal women: A potential long-term therapy with a depot GnRH agonist combined with hormonal replacement therapy
37. Morbidity of 10 110 hysterectomies by type of approach
38. The 'cons' of laparoscopic myomectomy is women who may reproduce in the future
39. Recurrent rate after laparoscopic myomectomy
40. Medical Research Council randomised trial of endometrial resection versus hysterectomy in management of menorrhagia
41. Randomised trial of hysterectomy, endometrial laser ablation and transcervical endometrial resection for dysfunctional uterine bleeding
42. The impact of laparoscopic surgery on vaginal hysterectomy
43. Arterial embolisation to treat uterine myomata
44. Pregnancy after embolization of uterine myoma: Report of 12 cases
45. RCOG/RCR report
46. Laparoscopic hysterectomy
47. Uterine artery embolization for fibroid disease
48. Quality of life among women underground hysterectomies
49. The effect of hysterectomy on the age at ovarian failure: Identification of a subgroup of women with premature loss of ovarian function and literature review
50. Outpatient uterine artery embolization for symptomatic uterine fibroids: Experience in 49 patients
51. 1
52. Uterine fibroids
53. A comparative study of adjuvant GnRH agonist (Zoladex®) therapy versus immediate surgery in the treatment of uterine myoma
54. Fertility after hysteroscopic myomectomy
55. Fatal septicaemia after fibroid embolisation
56. Abdominal myomectomy for infertility: A comprehensive review
57. The epidemiology of hysterectomy: Findings in a large cohort study
58. Uterine leiomyomata: Etiology, symptomatology and management
59. Goserelin (Zoladex®) in the treatment of fibroids
60. Endoscope treatment of uterine fibroids
61. Uterine arterial embolization for the management of leiomyomas: Quality-of-life assessment and the clinical response
62. Transcatheter arterial embolization of obstetric and gynaecologic bleeding: Efficacy and clinical outcome